$4.080
+0.324 (+7.94%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Prelude Therapeutics Inc (PRLD) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting PRLD is Buy.
Prelude Therapeutics Inc (PRLD) 20-Day simple moving average is 3.70, while Prelude Therapeutics Inc (PRLD) share price is $—, making it Buy.
Prelude Therapeutics Inc (PRLD) 60-Day simple moving average is 4.58, while Prelude Therapeutics Inc (PRLD) share price is $—, making it Sell.
Technical Analysis for PRLD
AI Technical PRLDAs of 2026-11-03, the technical board for Prelude Therapeutics Inc (PRLD) reads buy: 7 indicators are flashing buy, 2 are indicating sell, and 4 are neutral. Price at $4.08 sits below the 60-day moving averages and above the 5-day, 10-day, 20-day and 200-day.
Momentum readings: RSI stands at 54.86, MACD stands at -0.0533 (Sell), Stochastic %K stands at 67.29, Stochastic %D stands at 66.459 and CCI stands at 88.115.
PRLD trades below the 60-day SMA (4.58) and above the 200-day SMA (4.04). Immediate resistance sits at Classic R1 4.28, then R2 4.69. Support sits at Classic S1 3.43, then S2 2.99.
Prelude Therapeutics Inc (PRLD) Support & Resistance Level
Prelude Therapeutics Inc (PRLD) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 54.860 |
| STOCHk_14_3_3 | 67.290 |
| STOCHd_14_3_3 | 66.459 |
| CCI_20 | 88.115 |
| AO_5_34 | 0.120 |
| MOM_10 | 0.430 |
| MACD_12_26_9 | -0.053 |
Prelude Therapeutics Inc (PRLD) Relative Strength Index (RSI_14) is 54.860, creating a Neutral signal.
Prelude Therapeutics Inc (PRLD) Stochastic %K is 67.290, creating a Neutral signal.
Prelude Therapeutics Inc (PRLD) Stochastic %D is 66.459, creating a Neutral signal.
Prelude Therapeutics Inc (PRLD) CCI_20 is 88.115, creating a Neutral signal.
Prelude Therapeutics Inc (PRLD) Awesome Oscillator (AO) is 0.120, creating a Buy signal.
Prelude Therapeutics Inc (PRLD) Momentum (MOM) is 0.430, creating a Buy signal.
Prelude Therapeutics Inc (PRLD) Moving Average Convergence Divergence (MACD) is -0.053, creating a Sell signal.
Prelude Therapeutics Inc (PRLD) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.936 | Buy |
| MA_10 | 3.863 | Buy |
| MA_20 | 3.704 | Buy |
| MA_60 | 4.579 | Sell |
| MA_200 | 4.041 | Buy |
| MA_250 | 3.616 | Buy |
Prelude Therapeutics Inc (PRLD) 5-Day simple moving average is 3.936, while Prelude Therapeutics Inc (PRLD) share price is $, making it a Buy.
Prelude Therapeutics Inc (PRLD) 10-Day simple moving average is 3.863, while Prelude Therapeutics Inc (PRLD) share price is $, making it a Buy.
Prelude Therapeutics Inc (PRLD) 20-Day simple moving average is 3.704, while Prelude Therapeutics Inc (PRLD) share price is $, making it a Buy.
Prelude Therapeutics Inc (PRLD) 60-Day simple moving average is 4.579, while Prelude Therapeutics Inc (PRLD) share price is $, making it a Sell.
Prelude Therapeutics Inc (PRLD) 200-Day simple moving average is 4.041, while Prelude Therapeutics Inc (PRLD) share price is $, making it a Buy.
Prelude Therapeutics Inc (PRLD) 250-Day simple moving average is 3.616, while Prelude Therapeutics Inc (PRLD) share price is $, making it a Buy.
Related articles
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.